Sequana Medical NV has announced the US FDA approval of its Alfapump system for treating recurrent or refractory ascites due to liver cirrhosis. This approval marks Alfapump as the first active ...

Background: Ascites and pleural effusion are well recognized complications of pancreatic diseases. Drug therapy of these is limited by high cost, prolonged hospitalization and failure rates ...

Fatty liver disease can show visible signs. These visible signs on the body might indicate fatty liver or other liver-related ...

alfapump® is the first US approved active implantable medical device (Class III) for the treatment of recurrent or refractory ascites due to liver cirrhosis US market opportunity estimated at ...

This $250,000 grant is part of DDF's ongoing commitment to funding groundbreaking research that drives progress in the fight against gastric cancer. Since its founding, DDF has invested over $2 ...

Perhaps the ascites resulted from the swelling of the ... The unusual clinical course in this case is presented as a complication in the treatment of diabetic acidosis. It is hoped that this ...

Sequana Medical Announces US FDA Approval of alfapump® for the Treatment of Recurrent or Refractory Ascites due to Liver Cirrhosis The Company will be hosting a further webcast with key opinion ...

Treatment of ascites is initially based on diuretics, but randomized studies assessing the efficacy of different combinations of diuretics are very scarce. Angeli et al. compared the efficacy and ...

The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of recurrent or refractory ascites due to cirrhosis, according to a company press release.

Recurrent or refractory ascites is a severe condition characterized by the accumulation of fluid in the abdomen. The current standard treatment involves therapeutic paracentesis, an invasive and ...

Recurrent or refractory ascites is a severe condition characterized by the accumulation of fluid in the abdomen. The current standard treatment involves therapeutic paracentesis, an invasive and ...